X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Why the World Looks to the U.S. for the Most Elusive Cures

By Robert Zirkelbach  |    February 3, 2015
Research and development (R&D) is the backbone of the biopharmaceutical industry and the reason why we have seen more than 450 new medicines approved in the U.S. since 2000 to help fight cancer,...   Read More

Over $500 Billion Invested in R&D by PhRMA Member Companies Since 2000

By Robert Zirkelbach  |    January 22, 2015
Developing innovative, lifesaving medicines for patients is the sole focus of the biopharmaceutical industry. PhRMA member companies invested more than $50 billion in research and development (R&D)...   Read More

How We’re Curing The Incurable

By John Castellani  |    December 18, 2014
This post first appeared on the Morning Consult.  In 1989, while the world watched the Berlin Wall fall and history opened a new chapter, researchers in government and private labs half a world away...   Read More

Putting the IMS Health Global Forecast on Prescription Medicines in Perspective

By Robert Zirkelbach  |    November 20, 2014
Since 2000, biopharmaceutical companies have brought more than 450 new innovative medicines to the U.S. market, resulting in significant progress against some of the most costly and challenging...   Read More

Debunking the Myths of Treating Hepatitis C

By Robert Zirkelbach  |    November 4, 2014
Original publish date was 7/21/2014; this post was updated on 8/5/2014 and 11/4/2014. A national dialogue is needed around the value of new medicines and cures and the role they play in improving...   Read More

What They Are Saying About Patients’ Access to Medicines

By Robert Zirkelbach  |    October 1, 2014
Helping to ensure patients have access to the medicines they need is a top priority for the biopharmaceutical industry. Over the past 15 years, biopharmaceutical companies have had more than 400 new...   Read More

What They Are Saying about the Value of New Innovative Medicines

By Robert Zirkelbach  |    September 29, 2014
It’s not every day that a new treatment becomes available that is able to cure 90 percent of the patients. Yet that is exactly what has happened with new and forthcoming medicines to treat hepatitis...   Read More

What they are saying about new hepatitis C cure: “That's actually a great deal”

By Robert Zirkelbach  |    July 17, 2014
Vox’s Sarah Kliff talked to some health economists about the new cure for hepatitis C that has gotten so much attention in recent weeks.  What she heard may surprise you.  Check out her article here:    Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates